https://www.zacks.com/stock/news/2236362/gritstone-bio-inc-grts-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2236362
Mar 05, 2024 - Gritstone bio Inc. (GRTS) delivered earnings and revenue surprises of 27.78% and 116.31%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
zc:-5245180333520481714
0
https://www.zacks.com/stock/news/2236358/aquestive-therapeutics-aqst-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2236358
Mar 05, 2024 - Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of -50% and 12.05%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
zc:4323347125198737767
0
https://www.zacks.com/stock/news/2236330/lsb-lxu-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2236330
Mar 05, 2024 - LSB (LXU) delivered earnings and revenue surprises of -130% and 3.92%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
zc:-6283609451869830067
0
https://www.zacks.com/stock/news/2236280/plus-therapeutics-pstv-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2236280
Mar 05, 2024 - Plus (PSTV) delivered earnings and revenue surprises of 10.26% and 4.21%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
zc:-5119972895265731989
0
https://www.zacks.com/stock/news/2236282/cadre-holdings-inc-cdre-tops-q4-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2236282
Mar 05, 2024 - Cadre Holdings, Inc. (CDRE) delivered earnings and revenue surprises of 61.11% and 1.87%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
zc:-1980764566298908880
0
https://www.zacks.com/stock/news/2236273/aeva-technologies-inc-aeva-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2236273
Mar 05, 2024 - Aeva Technologies, Inc. (AEVA) delivered earnings and revenue surprises of 7.69% and 1.13%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
zc:4942771672159998344
0
https://www.zacks.com/commentary/2236265/3-top-ranked-stocks-to-buy-for-stability?cid=CS-ZC-FT-investment_ideas-2236265
Mar 05, 2024 - Targeting low-beta stocks can provide a valuable layer of stability for portfolios. After all, defense wins ballgames.
zc:251403302678507286
0
https://www.zacks.com/stock/news/2236177/are-you-looking-for-a-top-momentum-pick-why-veeco-instruments-veco-is-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2236177
Mar 05, 2024 - Does Veeco Instruments (VECO) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:-2901237556062727190
0
https://www.zacks.com/stock/news/2236187/are-you-looking-for-a-top-momentum-pick-why-y-mabs-therapeutics-inc-ymab-is-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2236187
Mar 05, 2024 - Does Y-mAbs Therapeutics, Inc. (YMAB) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:2626714405730122902
0